Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma
Dirk Schadendorf, Reinhard Dummer, Keith T. Flaherty, Caroline Robert, Ana Maria Arance, Jan Willem B. de Groot and 14 more
- Rank
- 6 of 1,155
- Percentile
- top 0.6%
- Where
- European Journal of Cancer, 2024
- Citations
- 83
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.